Optiscan Imaging Limited (ASX:OIL)
Optiscan Imaging Limited (ASX:OIL) is a global leader in the development of microscopic imaging and technologies for screening, surgery and medical research.
Optiscan has developed and patented endomicroscopic technology which enables real-time, 3D, ‘in vivo’ imaging of human tissue at the cellular level –effectively generating instant 'virtual biopsies' with applications for cancer screening and surgical margin determination.
Optiscan’s technology has the capability to improve patient welfare, reduce hospital costs, improve accuracy and reduce the need for multiple procedures and is approved for use in brain surgery. It is also involved in a number of oral cancer and breast cancer studies.